Postoperative adjuvant radiation therapy in the treatment of primary head and neck mucosal melanomas

ORL

Volumn 70, Issue 6, 2008, Pages 344-351

  Nakashima, Juliano P ^a   Viégas, Célia M ^a   Fassizoli, Ana L ^a   Rodrigues, Marcelo ^a   Chamon, Leonardo A G ^a   Silva, João H C ^a   Dias, Fernando L ^a   Araújo, Carlos M ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Head and neck mucosal melanoma; Prognostic factors; Radiotherapy; Survival rate; Timing, radiotherapy; Treatment failure

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER CONTROL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; OTORHINOLARYNGOLOGIC NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE CARE; PROBABILITY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 55549132293     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163029     Document Type: Article

References (40)

1. Chang AE, Karnell LH, Menck HR, American College of Surgeons Commission on Cancer and the American Cancer Society: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84836 cases from the past decade. Cancer 1998; 83: 1664-1678.
2. Andersen LJ, Berthelsen A, Hansen HS: Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 1992; 21: 180-185.
3. Lee SP, Shimizu KT, Tran LM, et al: Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope 1994; 104: 121-126.
4. American Joint Committee on Cancer: Head and Neck Sites, ed 6. New York, Springer, 2002, pp 17-87.
5. Medina JE, Ferlito A, Pellitteri PK, et al: Current management of mucosal melanoma of the head and neck (review). J Surg Oncol 2003; 83: 116-122.
6. Ballantyne AJ: Malignant melanoma of the skin of the head and neck: an analysis of 405 cases. Am J Surg 1970; 4: 425-431.
7. Shibuya H, Takeda M, Matsumoto S, et al: The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys 1993; 25: 35-39.
8. Harwood AR, Cummings BJ: Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 1982; 8: 1121-1126.
9. Rapini RP, Golitz LE, Greer RO Jr, et al: Primary malignant melanoma of the oral cavity. Cancer 1985; 55: 1543-1551.
10. Blatchford SJ, Koopmann CF Jr, Coulthard SW: Mucosal melanoma of the head and neck. Laryngoscope 1986; 96: 929-934.
11. Manolidis S, Donald PJ: Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997; 80: 1373-1386.
12. Thompson LD, Wieneke JA, Miettinen M: Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003; 27: 594-611.
13. Patel SG, Prasad ML, Escrig M, et al: Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24: 247-257.
14. Batsakis JG, Suarez P: Mucosal melanomas: a review. Anat Pathol 2000; 7: 167-180.
15. Lund VJ, Howard DJ, Harding L, et al: Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999; 109: 208-211.
16. Owens JM, Roberts DB, Myers JN: The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003; 129: 864-868.
17. Stern SJ, Guillamondegui OM: Mucosal melanoma of the head and neck. Head Neck 1991; 13: 22-27.
18. Guzzo M, Grandi C, Licitra L, et al: Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol 1993; 19: 316-319.
19. Trotti A, Peters LJ: Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol 1993; 9: 246-250.
20. Temam S, Mamelle G, Marandas P, et al: Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 2005; 103: 313-319.
21. Registro Hospitalar de Câncer do Hospital do Câncer. Rio de Janeiro, Instituto Nacional de Câncer.
22. Hintze J: NCSS and PASS. Number Cruncher Statistical System. NCSS, Kaysville, 2004. www.ncss.com.
23. Kaplan G, Meier P: Non-parametric estimation from incomplete observations. J Am Stat 1958; 53: 457-481.
24. Cox DR: Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
25. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
26. Zak FG, Lawson W: The presence of melanocytes in the nasal cavity. Ann Otol Rhinol Laryngol 1974; 83: 515-519.
27. Overgaard J, Overgaard M, Hansen PV, et al: Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 1986; 5: 183-192.
28. Lund VJ, Howard DJ, Harding L, Wei WI: Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 1999; 109: 208-211.
29. Gilligan D, Slevin NJ: Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses. Br J Radiol 1991; 64: 1147-1150.
30. Nandapalan V, Roland NJ, Helliwell TR, et al: Mucosal melanoma of the head and neck. Clin Otolaryngol Allied Sci 1998; 23: 107-116.
31. Krengli M, Masini L, Kaanders JH, et al: Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases - a Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2006; 65: 751-759.
32. Kingdom TT, Kaplan MJ: Mucosal melanoma of the nasal cavity and paranasal sinuses. Head Neck 1995; 17: 184-189.
33. Dewey DL: The radiosensitivity of melanoma cells in culture. Br J Radiol 1971; 44: 816-817.
34. Harwood AR, Cummings BJ: Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 1982; 8: 1121-1126.
35. Wada H, Nemoto K, Ogawa Y, et al: A multiinstitutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiat Oncol Biol Phys 2004; 59: 495-500.
36. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, Geara FB, Klotch DW, Goepfert H, Peters LJ: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
37. Buchholz TA, Austin-Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, Griffin TW: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993; 26: 23-35.
38. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A: Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 2003; 56: 755-763.
39. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW: Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2004; 58: 1461-1467.
40. Hanzely Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, Afra D: Role of early radiotherapy in the treatment of supratentorial WHO Grade II astrocytomas: longterm results of 97 patients. J Neurooncol 2003; 63: 305-312.